X

Trial Profile

Trial of Perioperative Endocrine Therapy - Individualising Care: FLT-PET sub-study

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 17 Jun 2016

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Anastrozole (Primary) ; Letrozole (Primary) ; Antineoplastics
Indications Breast cancer
Focus Therapeutic Use
Acronyms POETIC:FLT-PET

Most Recent Events

11 Jan 2015 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.
19 Feb 2014 Accrual to date is 4% as reported by United Kingdom Clinical Research Network.
19 Feb 2014 Planned End Date changed from 31 Dec 2013 to 17 Apr 2014 as reported by United Kingdom Clinical Research Network.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com